* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Gene Section BCL2 (B-cell leukemia/lymphoma 2) Atlas of Genetics and Cytogenetics
Gene expression programming wikipedia , lookup
Epigenetics in stem-cell differentiation wikipedia , lookup
Gene expression profiling wikipedia , lookup
Genome (book) wikipedia , lookup
Designer baby wikipedia , lookup
Neocentromere wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
X-inactivation wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Point mutation wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Gene Section Mini Review BCL2 (B-cell leukemia/lymphoma 2) Jean-Loup Huret Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France Published in Atlas Database: May 1998 Online updated version: http://AtlasGeneticsOncology.org/Genes/BCL2ID49.html DOI: 10.4267/2042/37449 This work is licensed under a Creative Commons Attribution-Non-commercial-No Derivative Works 2.0 France Licence. © 1998 Atlas of Genetics and Cytogenetics in Oncology and Haematology dimerization, especially with BAX; role of the BCL2 anti-apoptosis members in forming complexes with caspase-9 and APAF1 (homolog of the nematode CED4), which prevent them to initiate the protease cascade (through caspase-3 cytochrome C dependent activation and) leading to apoptosis. Identity Location: 18q21 DNA/RNA Homology With Ced9 (nematode C. elegans); with other member of the BCL2 family: 1- apoptosis inhibitors BCLX, MCL1, and 2- apoptosis inducers BAX, BAD, BIK, … Implicated in BCL2 (18q21) PAC 248E24 - Courtesy Mariano Rocchi. Description t(14;18)(q32;q21)/B-cell malignancies → IgH - BCL2 Telomere to centromere orientation; 3 exons; exon 1 and the 3' part of exon 3 are non coding. Disease B-cell NHL mainly; found in 80 to 90% of follicular lymphomas, 30% of diffuse large cell lymphomas. Prognosis According to the cyto-pathologic subtype: small cleaved cell follicular lymphomas have a good prognosis; large cell lymphomas have a worse prognosis; the t(14;18) may have no prognostic significance. Cytogenetics Complex karyotypes are frequent with +7, del(6q), +12, + X, … Hybrid/Mutated Gene 5' BCL2 translocated on chromosome 14 near JH (junctions genes of IgH) and C in 3'. Abnormal Protein No fusion protein, but promoter exchange; the immunoglobulin gene enhancer stimulates the expression of BCL2. Transcription 2 alternative transcripts (a and b); 5.1 kb mRNA; coding sequence: CDS 1459...2178. Protein Description 25 kDa; 205 amino acids (BCL2b) or 239 amino acids (BCL2a, which has, in addition, a hydrophobic tail for membrane anchorage; this tail seems necessary for anti apoptotic ability); contain homo/heterodimerization domains (BH) and NH domains. Expression Wide; in B and T cells in particular. Localisation Mainly in the membranes. mitochondrial membrane; other Function Antiapoptosis, through a possibly complex process; Atlas Genet Cytogenet Oncol Haematol. 1998;2(4) 113 BCL2 (B-cell leukemia/lymphoma 2) Huret JL Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993 Aug 27;74(4):609-19. Oncogenesis As BCL2 is an apoptosis inhibitor, cell death is delayed, and there is cell accumulation (more than real transformation). Taskén K, Skålhegg BS, Taskén KA, Solberg R, Knutsen HK, Levy FO, Sandberg M, Orstavik S, Larsen T, Johansen AK, Vang T, Schrader HP, Reinton NT, Torgersen KM, Hansson V, Jahnsen T. Structure, function, and regulation of human cAMPdependent protein kinases. Adv Second Messenger Phosphoprotein Res 1997;31:191-204,. Chronic lymphocytic leukaemia Oncogenesis BCL2 is hypomethylated in the promotor region, and, therefore, overexpressed. Hu Y, Benedict MA, Wu D, Inohara N, Núñez G. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA 1998 Apr 14;95(8):438691. References Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsmeyer S. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985 Jul;41(3):899-906. This article should be referenced as such: Huret JL. BCL2 (B-cell leukemia/lymphoma 2). Atlas Genet Cytogenet Oncol Haematol.1998;2(4):113-114. Cleary ML, Sklar J. Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985 Nov;82(21):7439-43. Atlas Genet Cytogenet Oncol Haematol. 1998;2(4) 114